Major depressive disorder Trials in Willingboro, United States
Conditions / Major depressive disorder / Willingboro, United States
Clinical trials for Major depressive disorder investigate a range of treatment strategies and patient populations.
17 total trials for this combination
Showing top 10 of 17 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01482221 | A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder | COMPLETED | PHASE2 |
| NCT01156415 | Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD) | TERMINATED | PHASE3 |
| NCT01428661 | Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder | COMPLETED | PHASE2/PHASE3 |
| NCT01435759 | SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder | COMPLETED | PHASE2 |
| NCT01153347 | A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT01152554 | A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT01110902 | Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD) | COMPLETED | PHASE3 |
| NCT01473381 | Safety and Efficacy of Vilazodone in Major Depressive Disorder | COMPLETED | PHASE4 |
| NCT01436175 | SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study | TERMINATED | PHASE3 |
| NCT01377194 | Safety and Efficacy of Levomilnacipran ER (Levomilnacipran SR) in Major Depressive Disorder | COMPLETED | PHASE3 |